NEW YORK (GenomeWeb) – Northwestern University researchers have assessed a blood-based biomarker panel for major depressive disorder, reporting in Translational Psychiatry today that it could distinguish
NEW YORK (GenomeWeb) – Most plasma metabolites follow a daily rhythm in their expression levels that is muted by sleep deprivation, according to a metabolomic study appearing in the Proceedings of the National Academy of Sciences today.
NEW YORK (GenomeWeb) – Medicare contractor Palmetto GBA has issued draft local coverage determinations stipulating reimbursement criteria for three multi-marker molecular diagnostics: Assurex Health's pharmacogenetic test for refractory depression, MDxHealth's ConfirmMDx epigenetic prostate cance
NEW YORK (GenomeWeb) – Neuropsychiatric molecular diagnostics firm Assurex today said that it has secured a $25 million credit facility and $7 million in investments.
The funds will be used to increase clinical adoption of the Mason, Ohio-based firm's GeneSight products.
NEW YORK (GenomeWeb News) – Sundance Diagnostics today announced an exclusive, worldwide licensing deal with the Max Planck Institute of Psychiatry aimed at developing and commercializing a genetic test for predicting the risk of suicide from use of antidepressants.
NEW YORK (GenomeWeb News) – Investigators at Hartford Hospital's Genetics Research Center and Institute of Living will use a nearly $1.3 million federal grant to study the use of pharmacogenomic approaches in choosing medications for psychiatric patients.